Register information Patent

DE file number : 60 2013 066 547.8 (Status: pending/in force, Query started: June 22, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTPatent
StatusSTPending/in force
21DE file number DAKZ60 2013 066 547.8
96EP file numberEAKZ13 86 0388.1
86WO file numberWAKZPCT/US2013/071397
97EP publication numberEPN2928475
87WO publication numberWPN2014088838
54Designation/titleTIFINAFLOXACIN-SUSPENSIONSZUSAMMENSETZUNGEN
51IPC main classICM
(ICMV)		 A61K 31/5383 (2006.01)
51IPC secondary class(es)ICS
(ICSV)		 A61K 9/00 (2006.01)
22DE application dateDATNov 22, 2013
96EP application dateEATNov 22, 2013
86WO application dateWATNov 22, 2013
43Date of first publicationOTJun 12, 2014
Date of publication of grantPETMar 4, 2020
71/73Applicant/ownerINHCurofin Pharma GmbH, 13125 Berlin, DE
72InventorINBOUDREAUX, Brent, G., Irving, TX 75063, US; BRIDLE, Mark, J., Fort Worth, TX 76134, US; HUYNH, Bryan, H., Fort Worth, TX 76116, US; GHOSH, Malay, Fort Worth, TX 76109, US; CHOWHAN, Masood, A., Arlington, TX 76016, US; ALANI, Laman, Fort Worth, TX 76132, US; KABRA, Bhagwati, P., Euless, TX 76039, US
74RepresentativeVTRGILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE
Address for service GILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE
33
31
32
Foreign priorityPRC
PRNA
PRDA
US
201261734268 P
Dec 6, 2012
Due dateFT
FG		Nov 30, 2025
Annual fee for the 13th year Patent fees
Patent division in charge 44
97EP language of publicationELANGEN - Englisch
84Designated EP contracting statesEDSAL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Published EP/WO documentsEPWOPNOriginal document: EP000002928475
Searchable text: EP000002928475
Original document: EP000002928475B1
Searchable text: EP000002928475B1
Original document: WO002014088838
Searchable text: WO002014088838
43Date of first publicationEVTJun 12, 2014
Date of the first transfer into DPMAregisterEREGTOct 15, 2015
Date of the (most recent) update in DPMAregisterREGTDec 6, 2024
(Show all update days)(Hide all update days)
  • Dec 6, 2024
    • Due date: changed
  • Jul 26, 2024
    • Procedures: Procedure relating to PCT application, Publication of PCT application, 12.06.2014: deleted
  • May 17, 2024; Mar 7, 2024; Feb 1, 2024; Dec 22, 2023; Nov 29, 2023; Feb 17, 2023; Dec 9, 2022; Dec 6, 2021; Jul 29, 2021; Feb 4, 2021; Jan 21, 2021; Dec 5, 2020; Jun 25, 2020; May 19, 2020; Mar 26, 2020; Feb 27, 2020; Feb 15, 2020; Feb 13, 2020; Aug 19, 2019; Jul 11, 2019; Sep 13, 2018
    • Historical data not available for this/these date(s)
  • Oct 15, 2015
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Procedure relating to PCT application WO publication Jun 12, 2014  Details anzeigen
2 Procedure relating to EP application EPO 1st publication Oct 14, 2015  Details anzeigen
3 Publications Publication of a mention regarding EP 1st publication by DPMA Nov 26, 2015 Nov 26, 2015 Details anzeigen
4 Procedure relating to EP application EPO publication of mention regarding patent grant (beginning of opposition period) Mar 4, 2020  Details anzeigen
5 Publications Publication by DPMA of mention regarding EP patent grant Mar 26, 2020 Mar 26, 2020 Details anzeigen
6 New applicant/owner details New applicant/owner details May 19, 2020 Jun 25, 2020 Details anzeigen
7 Procedure relating to EP application No opposition to patent grant filed, or opposition proceedings at EPO completed without decision Dec 7, 2020 Feb 25, 2021 Details anzeigen
8 New representative details New representative details Dec 21, 2023  Details anzeigen
9 New applicant/owner details New applicant/owner details Jan 31, 2024 Mar 7, 2024 Details anzeigen
View procedures Procedure relating to PCT application (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to PCT application
Legal/procedural statusVSTWO publication
Date of legal/procedural statusVSTTJun 12, 2014
View procedures Procedure relating to EP application (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO 1st publication
Date of legal/procedural statusVSTTOct 14, 2015
View procedures Publications (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication of a mention regarding EP 1st publication by DPMA
Date of legal/procedural statusVSTTNov 26, 2015
Issue numberHN48
YearPJ2015
Publication dateVTNov 26, 2015
Type of publicationPARTBibliographic data
View procedures Procedure relating to EP application (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTEPO publication of mention regarding patent grant (beginning of opposition period)
Date of legal/procedural statusVSTTMar 4, 2020
View procedures Publications (No.: 5)
INIDCriterionFieldContent Close details
Type of procedureVARTPublications
Legal/procedural statusVSTPublication by DPMA of mention regarding EP patent grant
Date of legal/procedural statusVSTTMar 26, 2020
Issue numberHN13
YearPJ2020
Publication dateVTMar 26, 2020
Type of publicationPARTBibliographic data
PartHTPart 5
View procedures New applicant/owner details (No.: 6)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTMay 19, 2020
Issue numberHN26
YearPJ2020
Publication dateVTJun 25, 2020
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHMerLion Pharmaceuticals GmbH, 13125 Berlin, DE
71/73Previous applicant/ownerINHFMerlion Pharmaceuticals, Pte., Ltd., Singapore, SG
View procedures Procedure relating to EP application (No.: 7)
INIDCriterionFieldContent Close details
Type of procedureVARTProcedure relating to EP application
Legal/procedural statusVSTNo opposition to patent grant filed, or opposition proceedings at EPO completed without decision
Date of legal/procedural statusVSTTDec 7, 2020
Issue numberHN8
YearPJ2021
Publication dateVTFeb 25, 2021
Type of publicationPARTBibliographic data
PartHTPart 3
Date of update of the procedureREGTFeb 4, 2021
View procedures New representative details (No.: 8)
INIDCriterionFieldContent Close details
Type of procedureVARTNew representative details
Legal/procedural statusVSTNew representative details
Date of legal/procedural statusVSTTDec 21, 2023
74RepresentativeVTRGILLE HRABAL Partnerschaftsgesellschaft mbB Patentanwälte, 40593 Düsseldorf, DE
74Previous representativeVTRFKöhler, Ferdinand, Dipl.-Biol. Dr. rer. nat., 40593 Düsseldorf, DE
Date of update of the procedureREGTDec 22, 2023
View procedures New applicant/owner details (No.: 9)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTJan 31, 2024
Issue numberHN10
YearPJ2024
Publication dateVTMar 7, 2024
Type of publicationPARTBibliographic data
PartHTPart 3
71/73Applicant/ownerINHCurofin Pharma GmbH, 13125 Berlin, DE
71/73Previous applicant/ownerINHFMerLion Pharmaceuticals GmbH, 13125 Berlin, DE
Date of update of the procedureREGTMar 7, 2024